SECsense Logo

AstraZeneca PLC Form 6-K Report: Voting Rights Update & Acquisition Insights

$AZN
Form 6-K
Filed on: 2025-03-12
Source
AstraZeneca PLC Form 6-K Report: Voting Rights Update & Acquisition Insights

Here are the key insights and information extracted from the financial report (Form 6-K) regarding AstraZeneca PLC:

  1. Filing Details:
  • Type: Form 6-K
  • Filing Date: March 12, 2025
  • Commission File Number: 001-11960
  1. Company Information:
  • Company Name: AstraZeneca PLC
  • Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom
  1. Reporting Period: The report covers the month of March 2025.
  2. Acquisition/Disposal of Voting Rights:
  • The report indicates the notification is due to an acquisition or disposal of voting rights.
  1. Holder of Voting Rights:
  • Entity: The Capital Group Companies, Inc.
  • Location: Los Angeles, USA
  1. Voting Rights Information:
  • Date Threshold Crossed: March 10, 2025
  • Date Issuer Notified: March 11, 2025
  • Percentage of Voting Rights Held: 5.000629%
  • Total Number of Voting Rights Held: 77,540,115
  • Previous Notification Percentage: 4.996796%
  1. Shareholder Details:
  • The Capital Group Companies, Inc. is the ultimate controlling person with multiple controlled undertakings involved in managing investment assets.
  1. Financial Instruments:
  • No financial instruments were reported that would affect voting rights.
  1. Legal and Regulatory Compliance:
  • The filing complies with the Securities Exchange Act of 1934, confirming the entity's adherence to regulatory requirements.
  1. Additional Notes:
    • Capital Research and Management Company and its affiliates manage assets on behalf of various investment clients but do not own shares directly for their own accounts.
    • The report includes a detailed chain of controlled undertakings, demonstrating the complex structure of the Capital Group Companies.

This document provides critical insights into shareholding changes and the corporate structure related to AstraZeneca PLC, which could be significant for investors and analysts monitoring voting rights and corporate governance.